AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ACRUX LTD

0.015

0.000

Volume:- -

Turnover:- -

Market Cap:6.16M

PE:-0.89

High:0.015

Open:0.015

Low:0.015

Close:0.015

52wk High:0.032

52wk Low:0.012

Shares:410.61M

Float Shares:300.39M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.017

EPS(LYR):-0.017

ROE:-276.58%

ROA:-69.27%

PB:6.02

PE(LYR):-0.89

Loading ...

Overview Company News Filings

ACRES Commercial Realty to Issue $879.5 Million in Debt Notes

MT Newswires Live

Antengene Presents at JPM: Strong Clinical Data Update and Strategic Focus on Next-Generation ADCs and TCEs

TÜV Rheinland Reinforces Global Contamination Control with Clean Room Validation Services

Acrux Ltd-Divestment of Prilocaine 2.5% and Lidocaine 2.5%, Cream

THOMSON REUTERS

Antengene Hosts 2025 R&D Day Showcasing Encouraging Clinical Data and Solid Progress with Investigational Programs

Acrux Ltd - All Figures in AUD

THOMSON REUTERS

Acrux Ltd-Acrux Receives $0.4M Advance on FY26 R&D Tax Incentive

THOMSON REUTERS

Acrux Ltd-Updated September Quarter Activities Statement and App4c

THOMSON REUTERS

Antengene Presents Latest Preclinical Data of ATG-201 (CD19 x CD3 TCE) at ACR 2025

ASX Growth Companies With High Insider Ownership Expecting Up To 55% Revenue Growth

Simply Wall St.

ASX Growth Companies With Insider Ownership October 2025

Simply Wall St.

ASX Growth Stocks With High Insider Ownership To Watch

Simply Wall St.

ASX Growth Leaders With High Insider Ownership September 2025

Simply Wall St.

ASX Growth Companies With High Insider Ownership To Watch

Simply Wall St.

Top 3 ASX Growth Stocks With Significant Insider Ownership

Simply Wall St.

Antengene to Present Latest Preclinical Results from ATG-201 (CD19xCD3 TCE) at ACR 2025

ASX Growth Stocks With High Insider Ownership

Simply Wall St.

BRIEF-Acrux Ltd Pots FY Loss Attributable Of A$5.9 Million

Acrux Signs 10-Year Licensing Deal For Dapsone Gel in Saudi Arabia

MT Newswires Live

BRIEF-Acrux Signs Agreement With Servacure For Dapsone Gel In Saudi Arabia

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ACR.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"ACR.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ACR.AU\",,,,,undefined,":{"symbol":"ACR.AU","market":"AU","secType":"STK","nameCN":"ACRUX LTD","latestPrice":0.015,"timestamp":1770700320000,"preClose":0.015,"halted":0,"volume":0,"delay":0,"changeRate":0,"nameEN":"ACRUX LTD","floatShares":300389644,"shares":410608528,"eps":-0.016899,"marketStatus":"Not Yet Opened","change":0,"latestTime":"02-10 16:12:00 AEDT","open":0.015,"high":0.015,"low":0.015,"amount":0,"amplitude":0,"askPrice":0.016,"askSize":389000,"bidPrice":0.015,"bidSize":2233053,"shortable":3,"etf":0,"ttmEps":-0.016899,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1770764400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.015,"openAndCloseTimeList":[[1770678000000,1770699600000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ACR.AU\",,,,,undefined,":{"symbol":"ACR.AU","floatShares":300389644,"roa":"-69.27%","roe":"-276.58%","lyrEps":-0.016881,"shares":410608528,"dividePrice":0,"high":0.015,"amplitude":0,"preClose":0.015,"low":0.015,"week52Low":0.012,"pbRate":"6.02","psRate":"5.18","week52High":0.032,"institutionHeld":0,"latestPrice":0.015,"committee":0.703286,"eps":-0.016899,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.016899,"open":0.015,"prevYearClose":0.015,"prevWeekClose":0.015,"prevMonthClose":0.015,"prevQuarterClose":0.015,"fiveDayClose":0.015,"twentyDayClose":0.015,"sixtyDayClose":0.016},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACR.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2024-02-23","symbol":"ACR.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1708606800000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACR.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ACR.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2605987174","title":"ACRES Commercial Realty to Issue $879.5 Million in Debt Notes","url":"https://stock-news.laohu8.com/highlight/detail?id=2605987174","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605987174?lang=en_us&edition=fundamental","pubTime":"2026-01-21 16:36","pubTimestamp":1768984580,"startTime":"0","endTime":"0","summary":"ACRES Commercial Realty  said Tuesday that it will issue through a subsidiary $879.5 million in non-recourse, floating-rate notes at a weighted-average cost of the one-month term secured overnight financing rate plus 168 basis points.The transaction is expected to close by Feb. 12.The notes are collateralized by around $1 billion of floating-rate first mortgage loans originated by the company and $200 million in cash, the company said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ACR","BK7096","BK7508","ACR.AU","BK4110"],"gpt_icon":0},{"id":"2603400937","title":"Antengene Presents at JPM: Strong Clinical Data Update and Strategic Focus on Next-Generation ADCs and TCEs","url":"https://stock-news.laohu8.com/highlight/detail?id=2603400937","media":"prnewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603400937?lang=en_us&edition=fundamental","pubTime":"2026-01-16 09:00","pubTimestamp":1768525200,"startTime":"0","endTime":"0","summary":"SHANGHAI and HONG KONG, Jan. 16, 2026 /PRNewswire/ -- Antengene Corporation Limited , a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines forautoimmune disease, solid tumors and hematological malignancies indications, announced that it recently presented at the 44th Annual J.P. Morgan Healthcare Conference held in San Francisco. At the conference, Antengene shared the latest data and clinical development plans for its core clinical asset, ATG-022 , as well as R&D progress on ATG-125 , its steric hindrance masking AnTenGager T cell engager  platform, and other key preclinical programs.Advancing clinical development across 1L to 3L gastric cancer: Antengene is currently conducting the Phase I/II CLINCH study and","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/antengene-presents-at-jpm-strong-clinical-data-update-and-strategic-focus-on-next-generation-adcs-and-tces-302662555.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0034235188.USD","IE00B3S45H60.SGD","LU0211328371.USD","LU0345770993.USD","LU1670627923.USD","IE00BFXG1179.USD","LU1629891620.HKD","ORR.AU","IE0034235295.USD","LU1064131342.USD","LU2065731478.USD","LU1084165304.USD","IE00BHPRN162.USD","CRS.AU","BK4534","LU0943347566.SGD","ORR","LU0208291251.USD","IND","LU2756315664.SGD","LU0417517546.SGD","LU0006306889.USD","LU0106831901.USD","IE00BKVL7J92.USD","LU1974910355.USD","IE00BN8TJ469.HKD","IND.AU","LU0820562030.AUD","LU0345769631.USD","LU0345770308.USD","LU0170899867.USD","LU2746668461.USD","ACR.AU","LU2023250843.SGD","BK4581","LU0820561818.USD","LU2430703095.HKD","CRS","LU1244550494.USD","ACR","LU2264538146.SGD","CR","LU0868494617.USD","BK7508","LU0106261372.USD","LU0251132253.USD","LU2106854487.HKD","LU0683600562.USD","LU0787776722.HKD"],"gpt_icon":0},{"id":"2592926282","title":"TÜV Rheinland Reinforces Global Contamination Control with Clean Room Validation Services","url":"https://stock-news.laohu8.com/highlight/detail?id=2592926282","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592926282?lang=en_us&edition=fundamental","pubTime":"2025-12-18 11:30","pubTimestamp":1766028600,"startTime":"0","endTime":"0","summary":"Clean rooms are engineered environments designed to tightly control airborne particles, microbial contamination, temperature, humidity and airflow. Their performance directly influences product safety, research accuracy and regulatory compliance. From vaccine production to semiconductor fabrication, even minor deviations can result in compromised output, financial losses or failed audits.Airflow Visualisation Studies to assess air movement and detect turbulence.Airborne Particle Count Testing for classification and monitoring compliance.HEPA/ULPA Filter Integrity Testing to verify filtration performance.Air Change Rate  and Ventilation Performance evaluations to ensure consistent environmental control.Recovery Time Testing to determine how quickly cleanliness levels are restored.Temperature and Humidity Mapping to confirm environmental stability.Microbial Sampling and Testing for aseptic and high-risk environments.","market":"fut","thumbnail":"https://mma.prnewswire.com/media/2845451/Clean_Room__Validation.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2845451/Clean_Room__Validation.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/tuv-rheinland-reinforces-global-contamination-control-with-clean-room-validation-services-302642175.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACR","BK7508","BK7096","ACR.AU","BK4110"],"gpt_icon":0},{"id":"2590544005","title":"Acrux Ltd-Divestment of Prilocaine 2.5% and Lidocaine 2.5%, Cream","url":"https://stock-news.laohu8.com/highlight/detail?id=2590544005","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590544005?lang=en_us&edition=fundamental","pubTime":"2025-12-12 06:26","pubTimestamp":1765492008,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nTUEZ6NNM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","ACR.AU","BK7096"],"gpt_icon":0},{"id":"2584906256","title":"Antengene Hosts 2025 R&D Day Showcasing Encouraging Clinical Data and Solid Progress with Investigational Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2584906256","media":"prnewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584906256?lang=en_us&edition=fundamental","pubTime":"2025-11-20 10:56","pubTimestamp":1763607360,"startTime":"0","endTime":"0","summary":"SHANGHAI and HONG KONG, Nov. 20, 2025 /PRNewswire/ -- Antengene Corporation Limited , a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercialising first-in-class and/or best-in-class medicines for autoimmune disease, solid tumors and hematological malignancies indications, announced that at the R&D Day taking place today, it will present the latest data and future plans for three mid/late-stage clinical programs, including ATG-022 , ATG-037 , and ATG-101 . The company will also share the latest progress on ATG-125 :A B7H3 x PD-L1 targeted therapy featuring\"IO + ADC\"dual-effect molecules for the treatment of solid tumors and its AnTenGagerT-cell engager  technology platform which incorporates steric hindrance masking, along with updates on several key preclinical programs.In addition, guest expert Prof. Xin Wang, Chief Physician, Drug Clinical Trial Center, National Cancer Center / Cancer Hospital of the Chinese Academy of Medica","market":"nz","thumbnail":"https://mma.prnewswire.com/media/2355066/ANTENGENE_EN_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2355066/ANTENGENE_EN_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/antengene-hosts-2025-rd-day-showcasing-encouraging-clinical-data-and-solid-progress-with-investigational-programs-302621100.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065732104.USD","PRGS","BK4006","BK7095","BK4187","IE00B66KJ199.SGD","IE00B19Z4B17.USD","BK7096","BK7508","BK4161","IE00B7SZL793.SGD","IE0031619046.USD","LU2065731478.USD","ORR.AU","BK4110","CR","LU0963586101.USD","IND.AU","BK4097","CRS.AU","ORR","ACR","ACR.AU","CRS"],"gpt_icon":0},{"id":"2583583964","title":"Acrux Ltd - All Figures in AUD","url":"https://stock-news.laohu8.com/highlight/detail?id=2583583964","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583583964?lang=en_us&edition=fundamental","pubTime":"2025-11-13 05:22","pubTimestamp":1762982522,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nTUE3QXPS0:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7096","ACR.AU"],"gpt_icon":0},{"id":"2583583950","title":"Acrux Ltd-Acrux Receives $0.4M Advance on FY26 R&D Tax Incentive","url":"https://stock-news.laohu8.com/highlight/detail?id=2583583950","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583583950?lang=en_us&edition=fundamental","pubTime":"2025-11-13 05:22","pubTimestamp":1762982522,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nTUE3QXPS0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","ACR.AU","BK7096"],"gpt_icon":0},{"id":"2580292622","title":"Acrux Ltd-Updated September Quarter Activities Statement and App4c","url":"https://stock-news.laohu8.com/highlight/detail?id=2580292622","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580292622?lang=en_us&edition=fundamental","pubTime":"2025-11-04 06:20","pubTimestamp":1762208429,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nTUE6MDKYH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7096","ACR.AU"],"gpt_icon":0},{"id":"2578643636","title":"Antengene Presents Latest Preclinical Data of ATG-201 (CD19 x CD3 TCE) at ACR 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2578643636","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578643636?lang=en_us&edition=fundamental","pubTime":"2025-10-27 09:00","pubTimestamp":1761526800,"startTime":"0","endTime":"0","summary":"SHANGHAI and HONG KONG, Oct. 27, 2025 /PRNewswire/ -- Antengene Corporation Limited , a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercialising first-in-class and/or best-in-class medicines for autoimmune disease, solid tumors and hematological malignancies indications, today announced that the latest preclinical data of ATG-201  were presented in a Poster Presentation at the 2025 American College of Rheumatology  Annual Meeting, taking place from October 24th to October 29th in Chicago, IL, the United States. ATG-201 is a lead program developed using AnTenGager, the company's proprietary T-cell engager  platform which features \"2+1\" bivalent binding for low-expressing targets, steric hindrance masking, and proprietary CD3 sequences with fast on/off kinetics to minimize cytokine release syndrome  and enhance efficacy.In in vitro studies, ATG-201 demonstrated stronger B cell depletion activity in peripheral blood mononuclear c","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/antengene-presents-latest-preclinical-data-of-atg-201-cd19-x-cd3-tce-at-acr-2025-302593957.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4006","BK7095","BK4187","IE00B66KJ199.SGD","IE00B19Z4B17.USD","BK4181","BK7096","BK7508","IE00B7SZL793.SGD","BK4077","IE0031619046.USD","LU2065731478.USD","BK4110","LU0963586101.USD","IND.AU","CRS.AU","PK","BK4218","ACR","ACR.AU","SLE","CRS"],"gpt_icon":0},{"id":"2575763114","title":"ASX Growth Companies With High Insider Ownership Expecting Up To 55% Revenue Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2575763114","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575763114?lang=en_us&edition=fundamental","pubTime":"2025-10-16 03:08","pubTimestamp":1760555284,"startTime":"0","endTime":"0","summary":"The Australian stock market has shown resilience, with the ASX200 up 10% over the past ten months, despite a quiet September. As critical minerals and healthcare sectors gain momentum amid geopolitical shifts, investors are increasingly looking at growth companies with high insider ownership as potential opportunities.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/2054000-choice2-main-header/1585187245570","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2054000-choice2-main-header/1585187245570"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-ipx/iperionx-shares/news/asx-growth-companies-with-high-insider-ownership-expecting-u-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-ipx/iperionx-shares/news/asx-growth-companies-with-high-insider-ownership-expecting-u-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["TTT.AU","AV1.AU","IPX.AU","XAO.AU","BK7116","FND.AU","BK7158","NWF.AU","EIQ.AU","BK7104","BK7508","XKO.AU","BK7062","BK7016","BK7095","BK7096","3DP.AU","WZR.AU","MEK.AU","BK7093","XJO.AU","EMR.AU","BK7043","BK7036","ACR.AU","IR1.AU","PNI.AU"],"gpt_icon":0},{"id":"2574906930","title":"ASX Growth Companies With Insider Ownership October 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2574906930","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574906930?lang=en_us&edition=fundamental","pubTime":"2025-10-09 03:15","pubTimestamp":1759950920,"startTime":"0","endTime":"0","summary":"As the Australian market ended slightly in the red midweek, with gold prices reaching record highs and sectors experiencing mixed performances, investors are keenly observing trends that could influence future growth opportunities. In this context, companies with high insider ownership often attract attention as they can signal confidence from those who know the business best.","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-ltr/liontown-resources-shares/news/asx-growth-companies-with-insider-ownership-october-2025","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-ltr/liontown-resources-shares/news/asx-growth-companies-with-insider-ownership-october-2025","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["FND.AU","LTR.AU","BK7508","BK7016","IPX.AU","AYA.AU","BK7096","BK7094","XKO.AU","BK7043","BK7036","XJO.AU","BK7017","XAO.AU","BK7093","BK7095","IR1.AU","NWF.AU","BK7116","AV1.AU","WZR.AU","A4N.AU","EIQ.AU","3DP.AU","TTT.AU","BK7104","BK7158","BK7504","ACR.AU"],"gpt_icon":0},{"id":"2572566669","title":"ASX Growth Stocks With High Insider Ownership To Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2572566669","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572566669?lang=en_us&edition=fundamental","pubTime":"2025-10-02 03:08","pubTimestamp":1759345697,"startTime":"0","endTime":"0","summary":"The Australian market is navigating a complex landscape marked by high local inflation, an RBA pause, and geopolitical tensions, all contributing to volatility in sectors such as utilities and discretionary spending. In this environment of uncertainty, growth companies with high insider ownership can offer a unique perspective on potential resilience and alignment of interests between management and shareholders.","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/2024000-choice2-main-header/1585186739035","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2024000-choice2-main-header/1585186739035"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-ttt/titomic-shares/news/asx-growth-stocks-with-high-insider-ownership-to-watch-7","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-ttt/titomic-shares/news/asx-growth-stocks-with-high-insider-ownership-to-watch-7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7104","TTT.AU","EMR.AU","3DP.AU","XKO.AU","BK7095","ACR.AU","BK7016","FND.AU","VSL.AU","BK7096","BK7093","GTI.AU","XAO.AU","BK7158","BK7116","EIQ.AU","NWF.AU","BK7036","LM8.AU","AV1.AU","BK7043","XJO.AU","WZR.AU","BK7129","BK7506","BK7508"],"gpt_icon":0},{"id":"2571350701","title":"ASX Growth Leaders With High Insider Ownership September 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2571350701","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571350701?lang=en_us&edition=fundamental","pubTime":"2025-09-30 03:08","pubTimestamp":1759172882,"startTime":"0","endTime":"0","summary":"As the Australian market navigates fluctuating foreign direct investment flows and a mixed performance across sectors, investors are closely watching for opportunities amidst these shifts. In this environment, growth companies with high insider ownership can be particularly appealing, as they often indicate strong confidence from those who know the business best.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/3112100-choice1-main-header/1585186815935","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3112100-choice1-main-header/1585186815935"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/commercial-services/asx-c79/chrysos-shares/news/asx-growth-leaders-with-high-insider-ownership-september-202","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/commercial-services/asx-c79/chrysos-shares/news/asx-growth-leaders-with-high-insider-ownership-september-202","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IMA.AU","BK7094","FND.AU","3DP.AU","BK7158","AV1.AU","XKO.AU","GTI.AU","C79.AU","UNI.AU","BK7093","WZR.AU","BK7096","TNE.AU","XJO.AU","NWF.AU","BK7016","BB1.AU","XAO.AU","EIQ.AU","BK7043","BK7116","BK7503","BK7050","BK7508","BK7095","ACR.AU","BK7064","BK7021"],"gpt_icon":0},{"id":"2569744101","title":"ASX Growth Companies With High Insider Ownership To Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2569744101","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569744101?lang=en_us&edition=fundamental","pubTime":"2025-09-24 03:08","pubTimestamp":1758654495,"startTime":"0","endTime":"0","summary":"As the Australian market shows signs of awakening from its September slumber, driven by positive movements in financials and defense sectors, investors are keenly observing growth opportunities amidst fluctuating conditions. In this context, companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business; here are three such ASX-listed growth companies worth watching.","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice2-main-header/1585186553865","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice2-main-header/1585186553865"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-min/mineral-resources-shares/news/asx-growth-companies-with-high-insider-ownership-to-watch-8","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-min/mineral-resources-shares/news/asx-growth-companies-with-high-insider-ownership-to-watch-8","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XKO.AU","FND.AU","BK7067","PWH.AU","BK7507","BK7043","BK7504","BK7104","NWF.AU","WZR.AU","IPX.AU","BK7508","BK7016","XAO.AU","BK7158","BK7095","EMR.AU","BK7093","MSB.AU","BK7501","ACR.AU","BK7051","XJO.AU","3DP.AU","MIN.AU","IMA.AU","BK7096","EIQ.AU","AV1.AU","BK7116"],"gpt_icon":0},{"id":"2569765893","title":"Top 3 ASX Growth Stocks With Significant Insider Ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2569765893","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569765893?lang=en_us&edition=fundamental","pubTime":"2025-09-23 03:08","pubTimestamp":1758568088,"startTime":"0","endTime":"0","summary":"The Australian market has seen a mixed start to the week, with the XJO making gains yet remaining below its recent highs, as sectors like materials lead while real estate lags. In this environment of uncertainty and sector-specific movements, growth companies with high insider ownership can be attractive options for investors seeking alignment between management and shareholder interests.","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/8131000-choice1-main-header/1585186656975","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8131000-choice1-main-header/1585186656975"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/software/asx-cat/catapult-sports-shares/news/top-3-asx-growth-stocks-with-significant-insider-ownership","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/software/asx-cat/catapult-sports-shares/news/top-3-asx-growth-stocks-with-significant-insider-ownership","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XAO.AU","BTL.AU","3DP.AU","BK7084","BK7067","XJO.AU","AV1.AU","NWF.AU","BK7508","ACR.AU","BK7095","BK7093","BK4139","BK7096","BK7043","FND.AU","BK7094","TLX","IMA.AU","TLX.AU","WZR.AU","GTI.AU","BB1.AU","BK7116","EIQ.AU","CAT.AU","BK7142","BK7158","XKO.AU","BK7016"],"gpt_icon":0},{"id":"2568268159","title":"Antengene to Present Latest Preclinical Results from ATG-201 (CD19xCD3 TCE) at ACR 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2568268159","media":"prnewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568268159?lang=en_us&edition=fundamental","pubTime":"2025-09-19 20:00","pubTimestamp":1758283200,"startTime":"0","endTime":"0","summary":"SHANGHAI and HONG KONG, Sept. 19, 2025 /PRNewswire/ -- Antengene Corporation Limited , a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for hematologic malignancies and solid tumors, today announced that it will release the latest preclinical data of ATG-201  in Poster Presentations at the 2025 American College of Rheumatology  Annual Meeting, taking place from October 24th to October 29th in Chicago, IL, the United States.AnTenGagerTMis Antengene's proprietary TCE 2.0 platform featuring \"2+1\" bivalent binding for low-expressing targets, steric hindrance masking, and proprietary CD3 sequences with fast on/off kinetics to minimize cytokine release syndrome  and enhance efficacy. These characteristics support the platform's broad applicability across autoimmune diseases, solid tumors and hematological malignancies indications. ATG-201 is a novel \"2+1\" CD19-targeted T-cell e","market":"sg","thumbnail":"https://mma.prnewswire.com/media/2355066/ANTENGENE_EN_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2355066/ANTENGENE_EN_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/antengene-to-present-latest-preclinical-results-from-atg-201-cd19xcd3-tce-at-acr-2025-302561366.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7095","IE0031619046.USD","LU0963586101.USD","BK7096","BK4006","IE00B19Z4B17.USD","BK4110","BK7508","ACR.AU","IE00B66KJ199.SGD","CRS.AU","LU2065731478.USD","ACR","CRS","IE00B7SZL793.SGD","IND.AU"],"gpt_icon":0},{"id":"2568031455","title":"ASX Growth Stocks With High Insider Ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2568031455","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568031455?lang=en_us&edition=fundamental","pubTime":"2025-09-17 03:08","pubTimestamp":1758049690,"startTime":"0","endTime":"0","summary":"The Australian market showed signs of resilience as the index rebounded, taking cues from Wall Street's recent highs and anticipating potential economic shifts with the upcoming U.S. rate cut decision. Amid these fluctuating conditions, growth companies with high insider ownership can offer unique insights into their potential stability and commitment to long-term success, making them an intriguing focus for investors seeking solid opportunities in a dynamic environment.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/3041000-choice1-main-header/1585186744280","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3041000-choice1-main-header/1585186744280"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/capital-goods/asx-dur/duratec-shares/news/asx-growth-stocks-with-high-insider-ownership-5","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/capital-goods/asx-dur/duratec-shares/news/asx-growth-stocks-with-high-insider-ownership-5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IMA.AU","FND.AU","3DP.AU","BK7158","AV1.AU","XKO.AU","GTI.AU","IPX.AU","WZR.AU","BK7093","DUR.AU","BK7096","XJO.AU","NWF.AU","BK7016","XAO.AU","EIQ.AU","BK7043","BK7116","BK7508","BK7095","BK7055","BK7023","ACR.AU","SKS.AU"],"gpt_icon":0},{"id":"2563109955","title":"BRIEF-Acrux Ltd Pots FY Loss Attributable Of A$5.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2563109955","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563109955?lang=en_us&edition=fundamental","pubTime":"2025-08-29 09:49","pubTimestamp":1756432188,"startTime":"0","endTime":"0","summary":"BRIEF-Acrux Ltd Pots FY Loss Attributable Of A$5.9 MillionAug 29 (Reuters) - Acrux Ltd ACR.AX:FY LOSS ATTRIBUTABLE A$5.9 MILLIONFY TOTAL REVENUE A$4.5 MILLIONFurther company coverage: ACR.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250829:nFWN3UK1DY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","BK7508","ACR.AU"],"gpt_icon":0},{"id":"2555052990","title":"Acrux Signs 10-Year Licensing Deal For Dapsone Gel in Saudi Arabia","url":"https://stock-news.laohu8.com/highlight/detail?id=2555052990","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555052990?lang=en_us&edition=fundamental","pubTime":"2025-07-31 14:16","pubTimestamp":1753942573,"startTime":"0","endTime":"0","summary":"Acrux  has signed a 10-year agreement with Servacure Trading to market and distribute its food and drug administration-approved Dapsone 5% Gel in Saudi Arabia, according to a Thursday filing with the Australian bourse.The product, launched in the US in April 2024 for treating acne vulgaris and available in 60g and 90g packs, will have its regulatory approval and manufacturing managed by Servacure under the agreement, the filing said.The company will earn a fixed fee per unit shipped monthly, with options to renew the contract after the initial term, the filing added.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ACR.AU","BK7096","BK7508"],"gpt_icon":0},{"id":"2555076253","title":"BRIEF-Acrux Signs Agreement With Servacure For Dapsone Gel In Saudi Arabia","url":"https://stock-news.laohu8.com/highlight/detail?id=2555076253","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555076253?lang=en_us&edition=fundamental","pubTime":"2025-07-31 09:34","pubTimestamp":1753925674,"startTime":"0","endTime":"0","summary":"BRIEF-Acrux Signs Agreement With Servacure For Dapsone Gel In Saudi ArabiaJuly 31  - Acrux Ltd ACR.AX:LICENSING PARTNERSHIP IN SAUDI ARABIA FOR DAPSONE 5%, GELSIGNS AGREEMENT WITH SERVACURE FOR DAPSONE GEL IN SAUDI ARABIAFurther company coverage: ACR.AX ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250731:nTUE4HK5S1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","BK7508","ACR.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":21,"code":"91000000","status":"200"}]}}